Opendata, web and dolomites

BCPPlus SIGNED

New directions in bicyclopentane research

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BCPPlus project word cloud

Explore the words cloud of the BCPPlus project. It provides you a very rough idea of what is the project "BCPPlus" about.

mild    bioisosteres       drugs    modification    cutting    template    edge    subject    halides    tricyclopentane    syntheses    receiving    radical    invention    structural    reaction    atra    occupy    bicyclo    polysubstituted    directionality    immature    date    bcp    expanded    previously    substituent    analogues    natural    found    biological    parent    strategy    inaccessible    scaffolds    organic    abundance    explored    tcp    activation    property    contemporary    tactics    space    attractive    functionalization    seeking    ring    relative    industry    hetero    themselves    accessible    routes    area    polycycles    susceptibility    transfer    solution    dimensions    metabolic       nature    motifs    pharmacological    generalized    atom    aryl    pharmaceutical    despite    lack    derivatives    pentane    candidates    alkyl    bcps    chemistry    mimic    synthesize    functionalize    revolutionize    additionally    industrial    explore    medicinal    positioning    diameters    drug    opening    pharmacokinetic    rigid    intellectual    exhibit    arene   

Project "BCPPlus" data sheet

The following table provides information about the project.

Coordinator
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 

Organization address
address: WELLINGTON SQUARE UNIVERSITY OFFICES
city: OXFORD
postcode: OX1 2JD
website: www.ox.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-07-02   to  2020-07-01

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) coordinator 183˙454.00

Map

 Project objective

The pharmaceutical industry is increasingly seeking new tactics for the structural modification of drug candidates to avoid metabolic susceptibility, or to improve pharmacokinetic properties. Analogues called 'bioisosteres', which mimic the dimensions and substituent directionality of problematic structural motifs, but which are not themselves subject to the same pharmacological issues, offer one solution. Often based on scaffolds not found in ‘typical’ drug candidates, bioisosteres can additionally occupy new areas of intellectual property space. Within this growing field, rigid polycycles such as bicyclo[1.1.1]pentane (BCP) are receiving significant attention as arene bioisosteres, as they exhibit similar ring diameters and substituent positioning, and also improve many pharmacokinetic properties relative to the parent arene. Despite the attractive nature of these motifs and current interest, the lack of general routes to complex BCP ring systems means this template is not yet fully accessible to industry. The invention of mild methods for [1.1.1.0]tricyclopentane (TCP) ring opening and functionalization could revolutionize use of BCPs in the pharmaceutical sector. One method not explored to date is an atom transfer radical addition reaction (ATRA) strategy. Using aryl or alkyl halides, ATRA could deliver an abundance of previously inaccessible polysubstituted BCPs from generalized TCP, which would revolutionize this immature, cutting-edge area of organic and medicinal chemistry. This research proposal seeks to: i) explore general and mild ATRA-based syntheses of BCP derivatives, including ring-expanded (hetero)bioisosteres; ii) functionalize BCP products using a range of contemporary processes, including C–H or C–X activation; and iii) apply these methodologies to synthesize BCP drugs / natural product analogues, and to test their biological activity via an industrial collaboration.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BCPPLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BCPPLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PLECTRA (2020)

Revealing mechanisms of plant-soil feedback in search of trait indicators

Read More  

SNDTD (2019)

Resolving the origins of supernovae: constraining progenitors with integral field spectroscopy

Read More  

IQubitNet (2019)

Integrated multi-qubit devices for scalable quantum networks

Read More